Physician Exits From Medicare Increased in Vulnerable Areas
(MedPage Today) -- The number of physicians serving Medicare patients grew from 2013 to 2023, but program exit rates in ...
Cancer Study Links COVID Shots to Longer Survival
(MedPage Today) -- BERLIN -- Non-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be ...
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
(MedPage Today) -- CHICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted ...
Global Study Reports Rise in Several Cancers Among Adults of All Ages
(MedPage Today) -- Incidence of several cancers increased among adults of all ages in the past two decades, a global ...
Chemotherapy-Free Combo Improves Survival in Metastatic Colorectal Cancer
(MedPage Today) -- BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly improved overall survival (OS) ...
Primary Care Docs Spend This Many Hours Per Week Caring for Patients
(MedPage Today) -- Primary care physicians (PCPs) clocked more than 60 hours a week caring for their patient panel, a ...
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients
(MedPage Today) -- Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients' hospital stays were ...
Cannabis Commonly Used as a Sleep Aid Among Young Adults
Experts warn doing so may worsen sleep quality and raise the risk for substance abuse over time. Medscape Medical News ...
‘Awkward Moment’: Dr. Oz Interrupts Trump at Oval Office
(MedPage Today) -- In what some news reports dubbed "an awkward moment," CMS Administrator Mehmet Oz, MD, stepped up to ...
Diabetic Donor Corneas Show Success in Transplants for Endothelial Dysfunction
(MedPage Today) -- ORLANDO -- Receiving corneal tissue from donors with and without diabetes didn't negatively affect patients who underwent ...
FDA Approves Third-Ever Drug for Lupus Nephritis
Obinutuzumab (Gazyva) is the first drug to be approved for lupus nephritis since the approvals of belimumab (Benlysta) in 2020 ...
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
(MedPage Today) -- The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with ...
EV + Pembro Beats SOC in Cisplatin-Ineligible Bladder Cancer
Muscle-invasive bladder cancer patients who are ineligible or refuse cisplatin chemotherapy see “dramatic” improvements in survival outcomes with enfortumab vedotin ...
Rethinking the Apnea-Hypopnea Index for Measuring Obstructive Sleep Apnea
(MedPage Today) -- At World Sleep 2025, Robson Capasso, MD, of Stanford University in California, challenged the field's reliance on ...
Narcolepsy and Mortality Risk: New Data
Narcolepsy is not associated with increased risk for mortality of any type, even among patients with a higher prevalence of ...
Understanding Osteoporosis in Older Men
(MedPage Today) -- Because osteoporosis is more prevalent in women, men with osteoporosis often are overlooked. According to the NIH, ...
Spotting Trends in Patients’ Tests
(MedPage Today) -- Someone once told me that if you order enough lab tests on a patient, you'll find something. ...
Paradigm Shift in Metastatic TNBC to Trop2-Targeted Antibody-Drug Conjugates
(MedPage Today) -- BERLIN -- Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for ...
Telehealth Medication Abortion Requests Doubled After Dobbs
(MedPage Today) -- Telehealth medication abortion requests nearly doubled in the months after the Dobbs v. Jackson Women's Health Organization ...
A distant comet is forming new rings while we watch in real time
Illustration of Chiron’s ringsDan Durda For the first time, astronomers are watching a ring system form in real time. The ...
